ProCE Banner Activity

Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

Podcast Episodes

Listen as expert faculty answer audience questions on personalized management of patients with MDS from a live symposium during ASH 2022.

Released: February 17, 2023

Expiration: February 16, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Bristol Myers Squibb

Geron

Karyopharm Therapeutics Inc.

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

María Díez Campelo, MD, PhD

Associate Professor
Department of Medicine
School of Medicine
University of Salamanca
Hematologist
Department of Hematology
University Hospital of Salamanca
Salamanca, Spain

María Díez Campelo, MD, PhD: consultant/advisor/speaker: Blueprint, Bristol Myers Squibb, Novartis, Takeda.

Rami Komrokji, MD

Vice Chair, Department of Malignant Hematology
Senior Member and Professor of Oncologic Sceinces
H. Lee Moffitt Cancer Center
Tampa, Florida

Rami Komrokji, MD: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, CTI BioPharma, Geron, Gilead Sciences, Jazz, Novartis, PharmaEssentia, Servier, Taiho, Takeda.

Amer Zeidan, MBBS, MHS

Professor of Internal Medicine
Chief, Division of Hematologic Malignancies
Assistant Medical Director, Hematology Clinical Trials Office (CTO)
Director, Hematology Early Therapeutics Research
Director, Leukemia and Myeloid Malignancies Program
Co-Leader, Leukemia and Myeloid Malignancies Clinical Research Team (CRT)
Section of Medical Oncology and Hematology, Department of Internal Medicine
Yale School of Medicine and Yale Comprehensive Cancer Center
New Haven, Connecticut

Amer Zeidan, MBBS, MHS: researcher: AbbVie, ADC Therapeutics, Amgen, Aprea, Astex, Boehringer Ingelheim, Cardiff Oncology, Celgene/Bristol-Myers Squibb, Incyte, Medimmune/AstraZeneca, Novartis, Otsuka, Pfizer, Takeda, Trovagene; consultant: Acceleron, Agios, Amgen, Aprea, Astellas, Astex, BeyondSpring, Boehringer Ingelheim, Cardiff Oncology, Celgene/Bristol-Myers Squibb, Cardinal Health, Daiichi Sankyo, Epizyme, Gilead Sciences, Incyte, Ionis, Janssen, Jazz, Kura, Novartis, Otsuka, Pfizer, Seattle Genetics, Syndax, Taiho, Takeda, Trovagene, Tyme.